Molecular Insights into Early-Onset Biliary Tract Cancer

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

September 17, 2026: Capacity Tariffs Delayed, Judge Orders Notice for Kennedy Center, More 8 min · 18 Sep 2026 · Bloomberg News Now

760 - Yellow Homebrew 59 min · 18 Sep 2026 · Not For Radio

213: Father Knows: Confessions.. 48 min · 18 Sep 2026 · Father Knows Something

NPR News: 09-17-2026 10PM EDT 4 min · 18 Sep 2026 · NPR News Now

Report any issue

Source

Recorded10 Apr 2025

Publisherfeeds.buzzsprout.com

Handlerec:1648144

Show notes

Alok Khorana, MD, Director of the Gastrointestinal Malignancies Program at Cleveland Clinic Cancer Institute, joins the Cancer Advances Podcast to break down the latest research on early-onset biliary tract cancer, diving into the genetic and molecular differences that set it apart. Listen as Dr. Khorana addresses the challenges in diagnosing and treating this cancer and the exciting potential for personalized therapies tailored to these molecular discoveries.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in